Emergence of carbapenem-resistant ST131 Escherichia coli carrying bla OXA-244 in Germany, 2019 to 2020.

Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
Sybille WelkerDennis Nurjadi

Abstract

The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 Escherichia coli in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing E. coli may be under-reported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 E. coli is of clinical relevance and should be monitored closely.

Citations

Jul 24, 2021·Journal of the American Medical Directors Association·Philipp KohlerDelphine Héquet

❮ Previous
Next ❯

Datasets Mentioned

BETA
PRJNA546126

Methods Mentioned

BETA
PCR

Software Mentioned

Abricate
Spades
- ANNNOT )
Resfinder
Prokka
CGE Serotype Finder

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Nicola K PettyScott A Beatson
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale
Jiangqing HuangBin Li
© 2021 Meta ULC. All rights reserved